Parkinson's Disease Trial, Recruiting NCT06390761 Sponsor: Xi'an No.3 Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06390761
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's disease and also have a diagnosed condition of ongoing constipation (based on specific standard medical definitions for each condition)
  • People aged between 35 and 80 years old
  • People whose Parkinson's disease symptoms are at a moderate level or below on a standard rating scale (Hoehn-Yahr grade 3 or lower — confirm with trial site if unsure what grade applies)
  • People who have not taken any medications that may affect gut function (such as certain bowel medications or probiotics) in the two weeks before joining
  • People who have not participated in another clinical trial within the past month
  • People who are willing to take part, able to sign a consent form, and able to keep a bowel diary and complete questionnaires throughout the trial

Who may not be able to join:

  • People who have a physical or structural problem in their digestive system, such as bowel blockages, intestinal scarring, tumours, or abnormalities of the gut
  • People who have had abdominal or bowel surgery that may have affected how the gut moves, or who have conditions such as diabetes or an overactive thyroid that can affect digestion
  • People with serious or life-threatening illnesses, such as severe heart disease or cancers
  • People with skin problems in areas where needles would be placed, or who are allergic to adhesives used to attach the acupuncture device to the skin
  • Women who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gejuan Zhang, Doctor, The dean

Phone: +8615934875839

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xi'an No.3 Hospital
Registry
ClinicalTrials.gov
Start date
30 April 2024
Est. completion
30 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The number of weekly CSBMs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov